Medicamento con contenido en miramistina

摘要

The invention relates to a pharmaceutical including benzyl­dimethyl­(3-[myristoylamino]propyl)ammonium chloride in the monohydrate form or in unhydrated form. The pharmaceutical further comprises dimethyl­(3-[myristoylamino]propyl)ammonium oxide and/or dimethyl(3-[myristoyl­amino]propyl)amine in the appropriate pharmaceutical solvent.